Consumer health company Kenvue Inc. said July 30 its board of directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2% increase compared with the prior quarterly dividend.Â
The quarterly dividend is payable on Aug. 27, 2025, to shareholders of record as of the close of business on Aug. 13, 2025.
Among Kenvue’s brands are Aveeno, Band-Aid brand, Listerine, Neutrogena, and Tylenol.
Kenvue was formerly the Consumer Healthcare division of Johnson & Johnson before the health-care giant announced it was spinning off the division in November 2021. On Sept. 28, 2022, Johnson & Johnson said the new consumer health company would be called Kenvue. This past March, Kenvue opened its new 290,000-square-foot global headquarters in Summit, officially moving its headquarters from Skillman.
Kenvue has a market cap of $42.49 billion. The shares trade on the Nasdaq Real Time market and have risen 3.68% so far this year to $22.14.Â
